Cuu Long Pharmaceutical JSC Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Net Sales

3,72,593.19

2,85,741.02

3,23,238.17

3,40,016.73

5,10,263.16

2,35,615.34

2,82,978.66

Other Operating Income

0.00

Total Operating income

3,72,593.19

2,85,741.02

3,23,238.17

3,40,016.73

5,10,263.16

2,35,615.34

2,82,978.66

Raw Material Cost

3,19,556.06

2,52,465.99

2,89,742.71

2,61,103.28

4,45,482.86

2,01,400.39

2,44,217.01

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

30,648.11

29,739.47

31,605.30

28,557.48

33,495.51

30,180.81

27,294.87

Power Cost

0.00

Manufacturing Expenses

12,573.22

12,952.71

13,473.51

10,129.11

6,024.05

5,979.62

6,506.97

Selling and Distribution Expenses

40,771.11

33,871.76

30,039.72

35,553.09

42,575.23

34,798.16

33,761.53

Other Expenses

-4,322.13

-4,269.22

-4,507.88

-3,868.66

-3,951.96

-3,616.04

-3,380.18

Total Expenditure (Excl Depreciation)

3,60,327.17

2,86,337.75

3,19,782.42

2,96,656.37

4,88,058.10

2,36,198.55

2,77,978.54

Operating Profit (PBDIT) excl Other Income

12266

-596.7

3455.7

43360.4

22205.100000000002

-583.2

5000.1

Other Income

7,874.54

8,180.60

8,355.30

944.05

7,945.31

8,881.53

15,784.54

Operating Profit (PBDIT)

33,965.88

21,316.69

25,526.07

56,447.28

39,704.62

17,833.18

30,359.65

Interest

12,573.22

12,952.71

13,473.51

10,129.11

6,024.05

5,979.62

6,506.97

Exceptional Items

0.00

Gross Profit (PBDT)

53,037.14

33,275.03

33,495.46

78,913.45

64,780.29

34,214.95

38,761.65

Depreciation

13,825.32

13,732.82

13,715.02

12,142.86

9,554.25

9,534.87

9,575.00

Profit Before Tax

7,567.34

-5,368.84

-1,662.46

34,175.31

24,126.33

2,318.70

14,277.69

Tax

3,774.17

424.04

1,403.42

9,018.51

5,054.98

755.23

3,053.32

Provisions and contingencies

0.00

Profit After Tax

3,657.50

-5,936.97

-3,216.74

25,012.71

18,924.62

1,414.36

11,091.46

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

3,657.50

-5,936.97

-3,216.74

25,012.71

18,924.62

1,414.36

11,091.46

Share in Profit of Associates

0.00

Minority Interest

135.67

144.10

150.85

144.09

146.73

149.11

132.91

Other related items

0.00

Consolidated Net Profit

3,793.17

-5,792.87

-3,065.89

25,156.79

19,071.35

1,563.46

11,224.37

Equity Capital

0.00

Face Value

10000.0

Reserves

15,01,693.64

14,98,036.14

15,03,973.11

15,09,189.85

14,84,177.14

14,64,996.75

14,63,582.39

Earnings per share (EPS)

50.07

-81.28

-44.04

342.45

259.1

19.36

151.85

Diluted Earnings per share

50.07

-81.28

-44.04

342.45

259.1

19.36

151.85

Operating Profit Margin (Excl OI)

3.29%

-0.21%

1.07%

12.75%

4.35%

-0.25%

1.77%

Gross Profit Margin

5.74%

2.93%

3.73%

13.62%

6.6%

5.03%

8.43%

PAT Margin

0.98%

-2.08%

-1.0%

7.36%

3.71%

0.6%

3.92%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Dec 2025 is -26.98% vs 31.15% in Dec 2024

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is -80.11% vs -34.12% in Dec 2024

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is -17.85% vs -28.10% in Dec 2024

Interest

YoY Growth in quarter ended Dec 2025 is 108.72% vs -14.06% in Dec 2024

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024

Compare Quarterly Results Of Cuu Long Pharmaceutical JSC With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(VND)

Change(%)

Net Sales

3,72,593.19

5,31,944.04

-1,59,350.85

-29.96%

Other Operating Income

0.00

Total Operating income

3,72,593.19

5,31,944.04

-1,59,350.85

-29.96%

Raw Material Cost

3,19,556.06

4,81,932.01

-1,62,375.95

-33.69%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

30,648.11

0.00

30,648.11

Power Cost

0.00

Manufacturing Expenses

12,573.22

28,388.75

-15,815.53

-55.71%

Selling and Distribution Expenses

40,771.11

77,372.19

-36,601.08

-47.31%

Other Expenses

-4,322.13

-2,838.87

-1,483.26

-52.25%

Total Expenditure (Excl Depreciation)

3,60,327.17

5,59,304.21

-1,98,977.04

-35.58%

Operating Profit (PBDIT) excl Other Income

12,266.03

-27,360.16

39,626.19

144.83%

Other Income

7,874.54

35,461.83

-27,587.29

-77.79%

Operating Profit (PBDIT)

33,965.88

52,608.12

-18,642.24

-35.44%

Interest

12,573.22

28,388.75

-15,815.53

-55.71%

Exceptional Items

0.00

Gross Profit (PBDT)

53,037.14

50,012.03

3,025.11

6.05%

Depreciation

13,825.32

44,506.45

-30,681.13

-68.94%

Profit Before Tax

7,567.34

-20,287.08

27,854.42

137.30%

Tax

3,774.17

10,098.13

-6,323.96

-62.63%

Provisions and contingencies

0.00

Profit After Tax

3,657.50

-4,863.53

8,521.03

175.20%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

3,657.50

-4,863.53

8,521.03

175.20%

Share in Profit of Associates

0.00

Minority Interest

135.67

-25,521.67

25,657.34

100.53%

Other related items

0.00

Consolidated Net Profit

3,793.17

-30,385.20

34,178.37

112.48%

Equity Capital

0.00

Face Value

10,000.00

0.00

Reserves

15,01,693.64

38,72,879.10

-23,71,185.46

-61.23%

Earnings per share (EPS)

50.07

-14.31

64.38

449.90%

Diluted Earnings per share

50.07

-14.31

64.38

449.90%

Operating Profit Margin (Excl OI)

3.29%

-5.14%

0.00

8.43%

Gross Profit Margin

5.74%

4.55%

0.00

1.19%

PAT Margin

0.98%

-0.91%

0.00

1.89%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 37,259.32 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 30.40% vs -11.60% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -26.98% vs 31.15% in Dec 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 379.32 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 165.48% vs -88.95% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -80.11% vs -34.12% in Dec 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 2,609.13 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is 98.62% vs -23.50% in Sep 2025

YoY Growth in quarter ended Dec 2025 is -17.85% vs -28.10% in Dec 2024

Quarterly - Interest

Interest 1,257.32 Million

in Dec 2025

Figures in Million

QoQ Growth in quarter ended Dec 2025 is -2.93% vs -3.87% in Sep 2025

YoY Growth in quarter ended Dec 2025 is 108.72% vs -14.06% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 3.29%

in Dec 2025

Figures in %

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024